Literature DB >> 8823779

Recurrent brain metastases.

E Alexander1, J S Loeffler.   

Abstract

Metastases of the brain are the most frequent metastatic neurologic complication of systemic cancer and are second only to metabolic encephalopathies as a cause of central nervous system dysfunction in cancer patients. Despite recent significant advances in the diagnosis and treatment of metastases to the brain, many patients will suffer from recurrence. Future advances in the use of chemotherapy, radiosurgery, and newer cancer therapy techniques may lead to further increases in the efficacy of treatment for recurrent brain metastases.

Entities:  

Mesh:

Year:  1996        PMID: 8823779

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  2 in total

1.  A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Authors:  L E Abrey; J D Olson; J J Raizer; M Mack; A Rodavitch; D Y Boutros; M G Malkin
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 2.  The Management of Brain Metastases-Systematic Review of Neurosurgical Aspects.

Authors:  Martin A Proescholdt; Petra Schödel; Christian Doenitz; Tobias Pukrop; Julius Höhne; Nils Ole Schmidt; Karl-Michael Schebesch
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.